Friday, March 03, 2017 12:09:55 PM
Blue and Gold Ventures LLC
http://www.otcmarkets.com/ajax/showFinancialReportById.pdf?id=166720
https://www.linkedin.com/in/brian-brick-379420108
http://www.zoominfo.com/s/#!search/profile/company?companyId=13538598&targetid=profile
Blue and Gold Ventures LLC Defunct company
345 North Maple Drive Suite 295
Beverly Hills, California 90210
United States
(310) 276-6743
(310) 276-6783 Fax
www.blueandgoldventures.com
Company Background & Description
Industry: Investment Banking , Finance
Company Attributes:
Company Description: Blue and Gold Ventures, LLC, founded in 1999, is a closed-ended management investment company investing in the securities of businesses that offer unique opportunities for growth. • BGV's mission is to assist Small and Micro-cap Companies with a comprehensive slate of services, including; Investment Banking , Debt & Equity, Bridge Financing, Equity Debt Lines , Business Consulting and Investor Relations. By combining experience and expert techniques, BGV can help clear a path towards profitability and success returning to chief executives and business managers their most valuable resource, time. BGV primarily considers, prior to investing with a company, its management, size, products, services, and the nature of the industry the company operates within. However, with all these factors fully weighed, by far the most important criteria is the quality of a company's management. • Blue and Gold Ventures, LLC is headquartered in North Tonawanda, New York with offices in Beverly Hills, California. To learn more about Blue and Gold Ventures, LLC click any item on our menu. Should you have any questions or comments, let us know by clicking our Contact Information .
http://www.blueandgoldventures.com/ COMING SOON
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM